PT. Kimia Farma Tbk.
Established : 16 Agustus 1971
Business Line : Health Services
Current Management :
President Director : Honesti Basyir
Financial Director : IGN Suharta Wijaya
Marketing Director : Pujianto
Production Director : Jisman Siagian
General Affair Director : Arief Pramuhanto
As a public company and as a state-owned listed company (BUMN) as well, Kimia Farma fully committed to implementing good corporate governance as a necessity and obligation as mandated by Law number 19/2003 on BUMN.
PT. Kimia Farma (Persero) Tbk is an integrated health services company, moving from upstream to downstream. Kimia Farma’s major business is in industry sector, which is supported by Research and Development, Marketing, Distribution, Pharmacy Retail, Clinic Laboratory and Health Clinic.
With the strong Research and Development support, the business segment which‘s managed by this parent company produces medicines and traditional medicine, iodine, quinine and its derivatives products, and vegetable oil. Five production facilities that were spread across major cities in Indonesia are the backbone of industrial segment, where the five of them has been certified from the Good Manufacturing Practice Medicine (CPOB) and ISO 9001 certified ISO 9002 and ISO 14001 from overseas institution (Llyod's, SGS, TUV).
The production made by Pharmacy Plant company both it is a chemical medicines, formulation, and herbal as well, divided into 6 (six) production lines i.e. ethical, OTC, generics, narcotics, licensing, and raw materials.
Almost all therapeutic classes been accommodated by the company’s product that consist of 385 product item and being marketed to the whole part of Indonesia area and being exported as well to overseas countries through distribution network of the company or who have an agreement with the company.
As part of its responsibility, Kimia Farma committed to ensuring a fixed supply of generic drugs to the market.